Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …

Context The role of adjuvant chemotherapy remains poorly defined for the management of
muscle-invasive bladder cancer (MIBC). The last meta-analysis evaluating adjuvant …

Cytotoxic chemotherapy is effective in debulking tumour masses initially; however, in some
patients tumours become progressively unresponsive after multiple treatment cycles …

Cross-sectional X-ray imaging has become the standard for staging most solid organ
malignancies. However, for some malignancies such as urinary bladder cancer, the ability to …

Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …

Histological and molecular analyses of urothelial carcinoma often reveal intratumoural and
intertumoural heterogeneity at the genomic, transcriptional and cellular levels. Despite the …

The role of immunotherapy in bladder urothelial cancers is rapidly expanding. Since the
initial second-line therapy approval for patients who fail prior platinum-based chemotherapy …

MicroRNAs (miRNAs), a class of small noncoding RNAs, regulate protein-coding gene
expression by repressing translation or cleaving RNA transcripts in a sequence-specific …

Bladder cancer is the most common malignancy of the urinary tract, presents the highest
recurrence rate among solid tumors and is the second leading cause of death in …

Background: Previous studies have revealed that miR-26a-5p and miR-26b-5p act as
tumour suppressors in various types of cancer tissues. Here, we aimed to investigate the …